Sejong Medical CEO changed from Son Kwan to Shin Yong-seop to respond to lawsuit for maintaining listing and reorganize management
Sejong Medical announced that as of June 30, 2026, the CEO has been changed from Son Kwan to Shin Yong-seop.
The reason for the change is to respond to a preliminary injunction lawsuit for maintaining listing status and to reorganize management for shareholder interests including relisting and alternative listing.
The new CEO Shin Yong-seop born in 1971 previously served as CEO of unlisted BSJ Holdings and holds no shares in the company.
[AI Summary]While this CEO change appears as a routine personnel shift, the context of responding to a listing maintenance lawsuit reflects the company's delisting risk and management uncertainty. Direct financial impact on shareholder value is limited but may change depending on the lawsuit outcome.